V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
T
TARSAI Stock Diagnostic Report

Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101

[MISTRAL] Tarsus has acquired ophthalmic medical assets, including IRX-101, for $75 million, strengthening its competitiveness in the eye care sector.

View Source Article ↗
AI CATALYST SCORE70 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

TARS Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-26 14:49:54TARS75MidView Report →
2026-08-06 19:01:38TARS80MidView Report →
2026-08-06 11:57:34TARS60MidView Report →
View Full History for TARS (Blueprint) →